Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
Louise Bowles, Sean Platton, Nada Yartey, Minal Dave, Kurtis Lee, Daniel P. Hart, Vickie MacDonald, Laura Green, Suthesh Sivapalaratnam, John Pasi, Peter MacCallum
Abstract
From New England Journal of Medicine, Bowles, L., Platton, S., Yartey, N., Dave, M., Lee, K., Hart, D.P., MacDonald, V., Green, L., Sivapalaratnam, S., Pasi, K.J. and MacCallum, P., Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. New England Journal of Medicine DOI: 10.1056/NEJMc2013656. Copyright © 2020 Massachusetts Medical Society. Reprinted with permission.
Topics & Concepts
Lupus anticoagulantPartial thromboplastin timeMedicineCoronavirus disease 2019 (COVID-19)Prothrombin timeCoagulation testingThromboplastinSystemic lupus erythematosusAnticoagulantCoagulation2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineGastroenterologyPathologyThrombosisDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesDermatological and COVID-19 studiesLong-Term Effects of COVID-19